Skip to main content
Peptide Intel Hub laboratory research video
Peptide Intel Hub

Research brief · Longevity

FOXO4-DRI

Retro-inverso peptide tool compound for senolytic research.

Class

Retro-inverso peptide

Half-life

Short

Studied in

Senolytic research models.

What it is

FOXO4-DRI is a retro-inverso peptide designed to disrupt the FOXO4–p53 interaction selectively in senescent cells, used as a tool compound in senolytic research.

Mechanism studied

Disrupts FOXO4–p53 interaction in senescent cells.

Research notes

  • A foundational reagent in peptide-based senolytic research.

Before sourcing any material

  • Confirm a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity).
  • Check the stated peptide content per vial, not just the gross vial mass.
  • Plan reconstitution volumes first so the vial size matches your protocol.
  • Verify what is lawful in your jurisdiction — these are in-vitro research reagents, not medicines.
Longevity research hubAll research briefsLatest research articles
Share
© 2026 Peptide Intel Hub · Marbella · Educational research reference · For in-vitro research use only
Independent publication — we sell nothing. Supplier disclosure

Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Regena Peptides and Regena.app (regena-peptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Regena Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.